K051307

Substantially Equivalent

SYNCHRON SYSTEMS BEBZODIAZAPINE (EBNZ) REAGENT

Applicant: Beckman Coulter, Inc.
Product code: JXM
Advisory panel: Clinical Toxicology
Date received: 2005-05-19
Decision date: 2005-06-13
Decision: Substantially Equivalent
Clearance type: Special
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.